These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20345239)

  • 1. Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts.
    Memoli MJ; Hrabal RJ; Hassantoufighi A; Eichelberger MC; Taubenberger JK
    Clin Infect Dis; 2010 May; 50(9):1252-5. PubMed ID: 20345239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan.
    Takashita E; Fujisaki S; Kishida N; Xu H; Imai M; Tashiro M; Odagiri T;
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1390-9. PubMed ID: 23745712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.
    Renaud C; Pergam SA; Polyak C; Jain R; Kuypers J; Englund JA; Corey L; Boeckh MJ
    Transpl Infect Dis; 2010 Dec; 12(6):513-7. PubMed ID: 21062390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013.
    Takashita E; Ejima M; Itoh R; Miura M; Ohnishi A; Nishimura H; Odagiri T; Tashiro M
    Euro Surveill; 2014 Jan; 19(1):. PubMed ID: 24434172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.
    Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Kuwahara T; Shimazu Y; Shimomura T; Watanabe S; Odagiri T;
    Euro Surveill; 2016 Jun; 21(24):. PubMed ID: 27336226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.
    Pizzorno A; Abed Y; Bouhy X; Beaulieu E; Mallett C; Russell R; Boivin G
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1208-14. PubMed ID: 22203589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.
    Pizzorno A; Bouhy X; Abed Y; Boivin G
    J Infect Dis; 2011 Jan; 203(1):25-31. PubMed ID: 21148493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
    Hurt AC; Ernest J; Deng YM; Iannello P; Besselaar TG; Birch C; Buchy P; Chittaganpitch M; Chiu SC; Dwyer D; Guigon A; Harrower B; Kei IP; Kok T; Lin C; McPhie K; Mohd A; Olveda R; Panayotou T; Rawlinson W; Scott L; Smith D; D'Souza H; Komadina N; Shaw R; Kelso A; Barr IG
    Antiviral Res; 2009 Jul; 83(1):90-3. PubMed ID: 19501261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
    Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
    Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient.
    Higgins RR; Beniprashad M; Chong-King E; Li Y; Bastien N; Low DE; Gubbay JB
    J Clin Microbiol; 2012 Jul; 50(7):2500-2. PubMed ID: 22535992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR.
    Hindiyeh M; Ram D; Mandelboim M; Meningher T; Hirsh S; Robinov J; Levy V; Orzitzer S; Azar R; Grossman Z; Mendelson E
    J Clin Microbiol; 2010 May; 48(5):1884-7. PubMed ID: 20220153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea.
    Kim HM; Lee N; Kim MS; Kang C; Chung YS
    Virol J; 2020 Jul; 17(1):94. PubMed ID: 32631440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
    Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir.
    Baz M; Abed Y; Boivin G
    Antiviral Res; 2007 May; 74(2):159-62. PubMed ID: 17137644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
    Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
    J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.
    McKimm-Breschkin JL; Rootes C; Mohr PG; Barrett S; Streltsov VA
    J Antimicrob Chemother; 2012 Aug; 67(8):1874-83. PubMed ID: 22563014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community- and hospital-acquired infections with oseltamivir- and peramivir-resistant influenza A(H1N1)pdm09 viruses during the 2015-2016 season in Japan.
    Hibino A; Kondo H; Masaki H; Tanabe Y; Sato I; Takemae N; Saito T; Zaraket H; Saito R
    Virus Genes; 2017 Feb; 53(1):89-94. PubMed ID: 27714496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid genotypic assay for detection of oseltamivir-resistant influenza A (H1N1) viruses.
    Hata M; Tanaka S; Yasui Y; Fujiwara N; Kobayashi S; Minagawa H
    J Clin Microbiol; 2010 May; 48(5):1983-4. PubMed ID: 20220172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.